Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Chara...

por Emery, Paul, Burmester, Gerd R, Naredo, Esperanza, Zhou, Yijie, Hojnik, Maja, Conaghan, Philip G
Publicado 2018

Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity

por Landewé, Robert, Ritchlin, Christopher T, Aletaha, Daniel, Zhang, Ying, Ganz, Fabiana, Hojnik, Maja, Coates, Laura C
Publicado 2019

Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eas...

por Opris-Belinski, Daniela, Erdes, Shandor F, Grazio, Simeon, Šenolt, Ladislav, Hojnik, Maja, Nagy, Orsolya, Marina, Diana, Szántó, Sándor
Publicado 2018

Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results

por Poddubnyy, Denis, Sieper, Joachim, Akar, Servet, Muñoz-Fernández, Santiago, Haibel, Hildrun, Hojnik, Maja, Ganz, Fabiana, Inman, Robert D
Publicado 2021

Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study

por Smolen, Josef S, Gladman, Dafna, McNeil, H Patrick, Mease, Philip J, Sieper, Joachim, Hojnik, Maja, Nurwakagari, Pascal, Weinman, John
Publicado 2019

Low Incidence of Inflammatory Bowel Disease Adverse Events in Adalimumab Clinical Trials Across Nine Different Diseases

por Elewaut, Dirk, Braun, Jürgen, Anderson, Jaclyn K., Arikan, Dilek, Chen, Su, Hojnik, Maja, De Craemer, Ann-Sophie, Curtis, Jeffrey R.
Publicado 2021

Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial

por van der Heijde, Désirée, Sieper, Joachim, Maksymowych, Walter P., Lambert, Robert G., Chen, Su, Hojnik, Maja, Anderson, Jaclyn K., Pangan, Aileen L.
Publicado 2018

Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomise...

por Landewé, Robert BM, Gensler, Lianne S, Poddubnyy, Denis, Rahman, Proton, Hojnik, Maja, Li, Xiaoqi, Liu Leage, Soyi, Adams, David, Carlier, Hilde, Van den Bosch, Filip
Publicado 2021

Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial

por Mease, Philip J, Kavanaugh, Arthur, Coates, Laura C, McInnes, Iain B, Hojnik, Maja, Zhang, Ying, Anderson, Jaclyn K, Dorr, Alexander P, Gladman, Dafna D
Publicado 2017

Musculoskeletal ultrasonography in routine rheumatology practice: data from Central and Eastern European countries

por Mandl, Peter, Baranauskaite, Asta, Damjanov, Nemanja, Hojnik, Maja, Kurucz, Reka, Nagy, Orsolya, Nemec, Petr, Niedermayer, Dora, Perić, Porin, Petranova, Tzvetanka, Pille, Andres, Rednic, Simona, Vlad, Violeta, Zlnay, Martin, Balint, Peter V.
Publicado 2016

Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biologica...

por Smolen, Josef S, Mease, Philip, Tahir, Hasan, Schulze-Koops, Hendrik, de la Torre, Inmaculada, Li, Lingnan, Hojnik, Maja, Sapin, Christophe, Okada, Masato, Caporali, Roberto, Gratacós, Jordi, Goupille, Philippe, Liu Leage, Soyi, Pillai, Sreekumar, Nash, Peter
Publicado 2020

Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double‐Blind Withdrawal Study

por Coates, Laura C., Pillai, Sreekumar G., Tahir, Hasan, Valter, Ivo, Chandran, Vinod, Kameda, Hideto, Okada, Masato, Kerr, Lisa, Alves, Denise, Park, So Young, Adams, David H., Gallo, Gaia, Hufford, Matthew M., Hojnik, Maja, Mease, Philip J., Kavanaugh, Arthur
Publicado 2021